Preview

Epilepsy and paroxysmal conditions

Advanced search

PROBLEMS OF PARANEOPLASTIC LIMBIC ENCEPHALITIS DIAGNOSIS

Full Text:

Abstract

Abstract: paraneoplastic limbic encephalitis (PLE) is clinical form of paraneoplastic neurological syndrome, an autoimmune disorder of the central nevrous system. The incidence of PLE is about 3 cases per 1,000 patients with cancer. PLE is characterized by acute or subacute development of memory disorders, symptomatic epilepsy, psychiatric disorders. The authors present the current data on the pathogenesis, clinical presentation, diagnosis, and treatment of PLE, a clinical case of symptomatic epilepsy in the 38-year-old man with PLE associated with testicular cancer.

About the Authors

N. A. Shnayder
Voyno-Yasenetsky Krasnoyarsk State Medical University
Russian Federation


D. V. Dmitrenko
Voyno-Yasenetsky Krasnoyarsk State Medical University
Russian Federation


Yu. A. Dykhno
Voyno-Yasenetsky Krasnoyarsk State Medical University
Russian Federation


V. V. Ezhikova
Krasnoyarsk Regional Cancer Center named after A.I. Kryzhanowski
Russian Federation


References

1. Блинов Д.В. Общность ряда нейробиологических процессов при расстройствах деятельности ЦНС. Эпилепсия и пароксизмальные состояния. 2011; 2: 28-33.

2. Блинов Д.В. Cовременные подходы к патогенезу и прогнозированию исходов гипоксически-ишемического поражения цнс в перинатальном периоде. Акушерство, гинекология и репродукция. 2012; 3: 34-38.

3. Евтушенко С.К. Паранеопластические неврологические синдромы (клиника, диагностика и возможности лечения). Международный невролог. журн. 2011; 8 (46): 56-62.

4. Филиппов П.П. Паранеопластические антигены и ранняя диагностика рака. Соросовский образоват. журн. 2000; 6 (9): 3-9.

5. Шнайдер Н.А., Дыхно Ю.А., Ежикова В.В. Клиническая гетерогенность паранеопластического неврологического синдрома. Сиб. онколог. журн. 2011; 3 (45): 82-90.

6. Шнайдер Н.А., Дыхно Ю.А., Ежикова В.В., Кантимирова Е.А. Антионконевральные антитела и паранеопластический неврологический синдром. Рос. онколог. журн. 2012; 2: 49-53.

7. Шнайдер Н.А., Дмитренко Д.В., Дыхно Ю.А., Ежикова В.В. Паранеопластический лимбический энцефалит в практике невролога и онколога. Рос. онколог. журн. 2013; 1: 49-56.

8. Шнайдер Н.А., Дыхно Ю.А., Ежикова В.В. Структура и частота встречаемости паранеопластического неврологического синдрома при онкопатологии органов грудной клетки. Сиб. онколог. журн. 2012; 1 (49): 63-70.

9. Ahmad A.,Ramakrishna S., Meara J., Doran M. Autoimmune limbic encephalitis: a reversible form of rapidly progressive amnesia and seizures. Royal College of Physicians of Edinburgh. 2010; 40: 123-125.

10. Bataller L., Kleopa K.A., Wu G.F., Rossi J.E., Rosenfeld M.R., Dalmau J. Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J. Neurol. Neurosurg. Psychiatry. 2007; 78 (4): 381-385.

11. Basu S., Alavi A. Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates. Mol. Imaging. Biol. 2008; 10 (3): 131-137.

12. Bien C.G., Elger C.E. Limbic encephalitis: a cause of temporal lobe epilepsy with onset in adult life. Epilepsy Behav. 2007; 10: 529-538.

13. Buckley C., Oger J., Clover L. et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann. Neurol. 2001;50:73-78.

14. Corsellis J.A., Goldberg G.J., Norton A.R. Limbicencephalitis and its association with carcinoma. Brain. 1968; 91 (3): 481-496.

15. Chanson J.B., Diaconu M., Honnorat J., Martin T., De Seze J., Namer I.J., Hirsch E. PET follow-up in a case of anti-NMDAR encephalitis: arguments for cingulate limbicencephalitis.. Epileptic Disord.2012; 14 (1): 90-93.

16. Dalmau J., Rosenfeld M.R. Paraneoplastic syndromes of the CNS. Lancet Neurol. 2008; 7 (4): 327-340.

17. Dalmau J., Tüzün E., Wu H.Y., MasjuanJ., Rossi J.E., Voloschin A. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann. Neurol. 2007; 61: 25-36.

18. Darnell R.B., Posner J.B. Paraneoplastic syndromes affecting the nervous system. Semin. Oncol. 2006; 33: 270-298.

19. Dirr L.Y., Elster A.D., Donofrio P.D., Smith M. Evolution of brain MRI abnormalities in limbic encephalitis. Neurology. 1990; 40: 1304-1306.

20. Eloraby A.M. The paraneoplastic limbic encephalitis: MRI characterization of a deceiving neurological disorderJ. of the Egyptian Nat. Cancer Inst. 2008; 20 (4). 403-409.

21. Foster A.R., Jason P. Caplan J.P. Paraneoplastic limbic encephalitis. Psychosomatics. 2009; 50 (2): 108-113.

22. Grisold W., Giometto B., Vitaliani R., Oberndorfer S. Current approaches to the treatment of paraneoplastic encephalitis. Ther. Adv. Neurol. Disorders. 2011; 4 (4): 237-248.

23. Gultekin S.H., Rosenfeld M.R., Voltz R. et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumor association in 50 patients. Brain. 2000; 123: 1481-1494.

24. Haq R. Prognostic effect of early treatment of paraneoplastic limbic encephalitis in a patient with small-cell lung cancer. Curr. Oncol. 2012; 19 (5): 353-357.

25. Honnorat J., Antoine J.C., Derrington E. et al. Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes. J. Neurol. Neurosurg. Psychiatry. 1996; 61: 270-278.

26. Kroll-Seger J., Bien G.C., Huppertz H.-J. Non-paraneoplastic limbic encephalitis associated with antibodies to potassium channels leading to bilateral hippocampal sclerosis in pre-pubertal girl. Epileptic Disord. 2009; 11 (1): 54-59.

27. Kawano H., Hamaguchi E., Kawahito S. et el. Anaesthesia for a patient with paraneoplastic limbic encephalitis with ovarian teratoma: relationship to anti-N-methyl-d-aspartate receptor antibodies. Anaesthesia. 2011; 66 (6): 515-518.

28. Lalani N., Haq R. Prognostic effect of early treatment of paraneoplastic limbic encephalitis in a patient with small-cell lung cancer. Curr. Oncol.2012; 19: 353-357.

29. Lawn N.D., Westmoreland B.F., Kiely M.J. et al. Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin. Proc. 2003; 78:1363-1368.

30. Lee K-G. Paraneoplastic limbic encephalitis associated with ovarian teratoma. Clin. Med. 2012;12 (1): 95-96.

31. Lawn N.D., Westmoreland B.F., Kiely M.J., Lennon V.A., Vernino S. Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis . Mayo Clinic. Proc. 2003; 78 (11): 1363-1368.

32. Musunuru K., Darnell R.B. Paraneoplastic neurological disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration. Ann. Rev. Neurosci. 2001; 24: 239-262.

33. Pozo-Rosich P., Clover L., Saiz A., Vincent A., Graus F. Voltagegated potassium channel antibodies in limbic encephalitis. Ann. Neurol. 2003; 54: 530-533.

34. Rosenfeld M.R., Dalmau J. Paraneoplastic limbic encephalitis associated with small-cell lung cancer. Commun. Oncol. 2007; 4 (8): 491-494.

35. Sansing L.H., Tüzün E., Ko M.W., Baccon J., Lynch D.R., Dalmau J. A patient with encephalitis associated with NMDA receptor antibodies. Nat. Clin. Pract. Neurol. 2007; 3 (5): 291-296.

36. Thieben M.J., Lennon V.A., Boeve B.F., Aksamit A.J.,Keegan M., Vernino S. et al. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology. 2004; 62: 117 7-1182.

37. Tüzün E., MD, Dalmau J. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist. 2007; 13 (5): 261-271.

38. Tuzun E. Limbic Encephalitis associated with antibodies to cell membrane antigens. Neuropsychiatry 2007; 44: 101-107.

39. Uchuya M., Graus F., Vega F., Rene R., Delattre J.Y. Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. J. Neurol. Neurosurg. Psychiatry. 2000; 60: 388-392.

40. Urbach H., Soeder B.M., Jeub M., Klockgether T., Meyer B., Bien C.G. et. al. Serial MRI of limbic encephalitis. Neuroradiology. 2006; 48: 380-386.

41. Vincent A., Buckley C., Schott J.M. et al. Potassium channel antibodyassociated encephalopathy: a potentially immunotherapy — responsive form of limbic encephalitis. Brain. 2004; 127: 701-712.

42. White D., Beringe T. Paraneoplastic limbic encephalitis in an elderly patient with small cell lung carcinoma. Ulster Med J. 2010; 79 (1): 22-24.


Review

For citations:


Shnayder N.A., Dmitrenko D.V., Dykhno Yu.A., Ezhikova V.V. PROBLEMS OF PARANEOPLASTIC LIMBIC ENCEPHALITIS DIAGNOSIS. Epilepsy and paroxysmal conditions. 2013;5(3):49-58. (In Russ.)

Views: 483


ISSN 2077-8333 (Print)
ISSN 2311-4088 (Online)